CLINICAL_TRIALS
ClinicalTrials.gov record update
An Open-label Safety and Efficacy Study of VY-AADC01 Administered by MRI-Guided Convective Infusion Using a Posterior Trajectory Into the Putamen of Participants With Parkinson's Disease With Fluctuating Responses to Levodopa
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT03065192
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-28T10:38:45.393143+00:00
- Published At
- 2022-03-21T00:00:00+00:00
- Record Updated At
- 2022-03-21
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Idiopathic Parkinson\u0027s Disease", "Parkinson\u0027s Disease", "Basal Ganglia Disease", "Brain Diseases", "Central Nervous System Diseases", "Movement Disorders", "Nervous System Diseases", "Neurodegenerative Diseases", "Parkinsonian Disorders"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2022-03-21"- protocolSection.identificationModule.nctId
"NCT03065192"- protocolSection.identificationModule.officialTitle
"An Open-label Safety and Efficacy Study of VY-AADC01 Administered by MRI-Guided Convective Infusion Using a Posterior Trajectory Into the Putamen of Participants With Parkinson\u0027s Disease With Fluctuating Responses to Levodopa"- protocolSection.statusModule.overallStatus
"COMPLETED"- protocolSection.designModule.phases
["PHASE1"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.